Mortality and complications associated with percutaneous nephrostomy in patients with ureteral obstruction related to advanced cervical cancer
Keywords:
Nephrosotomy, percutaneous, adverse effects, urinay diversión, cervix neoplasms, mortalityAbstract
Introduction: Percutaneous nephrostomy is a well-established technique leading to the rapid resolution of ureteral obstruction and recovery of renal function in patients suffering from obstructive uropathy. However, its role in managing renal failure secondary to obstruction due to advanced abdominal neoplasia remains controversial.
Objective: Describing the demographic variables, the complications associated with intervention, the course of obstructive uropathy and several outcomes.
Materials and methods: 106 cases suffering from advanced cancer of the cervix and ureteral obstruction treated with percutaneous nephrostomy were included in the study. The patients were divided into 2 groups; 37 women with locally advanced, recently diagnosed cancer of the cervix which had not been treated so far were included in group A and 69 patients having recurrent tumours were included in group B.
Results: 106 women, aged 24 to 75 (46,2 mean, SD±13,1), were included in this study; 9 (8,5%) had cancer of the cervix stage IIB, 68 (64%) had tumours stage IIIB and 29 (27,5%) were suffering from IVA stage. 102 women received pelvic radiotherapy plus brachytherapy and 4 were treated with chemotherapy plus radiotherapy concomitantly. 90 patients were diagnosed as suffering bilateral urinary obstruction; this was unilateral in 16 of them. 90% of the patients had abnormal renal function tests when undergoing the procedure. 13,2% of the patients presented bleeding following the procedure, 26% had hydro-electrolytic alterations, 12% of the patients had intra- or peri-renal abscesses and 6% had an infection at the insertion site. The mean of how long nephrostomy was applied was 5,2 and 6,9 months for groups A and B respectively. 53% of the patients required 1 or more changes of catheter during this time and 147 episodes of infection of the urinary routes were documented (3,12 infections for each 100 days/catheter). Recurrent infection was more frequent in patients from group B (p=0,03), in those with an albumin level less than 2.5 mg/dl (p=0,011), in those who had been diagnosed as having rectal or vesicovaginal fistula (p = 0,02) and in those requiring more than 2 changes of catheter (p=0,05). 37% (n=39) of the patients died from sepsis having a urinary origin. Average stay in hospital (DPVU) was 71 days and mean survival 14,9 and 7,3 months in groups A and B, respectively. The average number of days of being hospitalised attributable to urinary infection following nephrostomy was 20,3 days.
Conclusion: DPVU is not recommendable in patients suffering from recurrent disease (in spite of having a good base functional state) due to the large proportion of ascribable complications, especially of infectious origin.
Author Biographies
Andrés Felipe Cardona, Instituto Nacional de Cancerología
Grupo de Oncología Clínica, Instituto Nacional de Cancerología E.S.E., Bogotá, D.C, Colombia
Javier Ricardo Garzón, Instituto Nacional de Cancerología
Grupo de Medicina Interna, Instituto Nacional de Cancerología E.S.E., Bogotá, D.C,, Colombia
Erick Burgos, Instituto Nacional de Cancerología
Grupo de Medicina Interna, Instituto Nacional de Cancerología E.S.E., Bogotá, D.C,, Colombia
Lina Maria Abenoza, Instituto Nacional de Cancerología
Grupo de Medicina Interna, Instituto Nacional de Cancerología E.S.E., Bogotá, D.C,, Colombia
Jorge Alberto Cortés, Instituto Nacional de Cancerología
Grupo de Infectología, Instituto Nacional de Cancerología E.S.E.
Pedro Luis Ramos, Instituto Nacional de Cancerología
Grupo de Oncología Clínica, Instituto Nacional de Cancerología E.S.E., Bogotá, D.C, Colombia
References
Robles S, White F, Peruga A. Trends in cervical cancer mortality in the Americas. Bull Pan Am Health Org 1996;30:290-301.
OPS. Health in the Americas. Bull Pan Am Health Org 1998;1:171-3.
Schainuck LI, Striker GE, Cutler RE, Benditt EP. Structural-functional correlations in renal disease. The correlations. Hum Pathol 1970; 1:631-41.
https://doi.org/10.1016/S0046-8177(70)80061-2
National Kidney, Urologic Diseases Advisory Board. The scope and impact of kidney and urologic diseases in long-range plan. NIH Publication #90-583 Washington, D.C. National Institutes of Health; 1990. p.7-35.
United States Renal Data System. Annual Data Report. II. Incidence and prevalence of ESRD. Am J Kidney Dis 1998;18(Suppl.2):S34-47.
Pastor AM. Nefrostomia percutánea. ¿Y ahora qué...? Enfermería Integral 2001;67:8-10.
Chan S, Robinson AC, Johnson RJ. Percutaneous nephrostomy: its value in obstructive uropathy complicating carcinoma of cervix uterus. Clin Oncol (R Coll Radiol) 1990;2:156-8.
https://doi.org/10.1016/S0936-6555(05)80150-5
Soper JT, Blaszczyk TM, Oke E, Clarke-Pearson D, Creasman WT. Percutaneous nephrostomy in gynecologic oncology patients. Am J Obstet Gynecol 1988;158:1126-31.
https://doi.org/10.1016/0002-9378(88)90237-2
Watkinson AF, AHern RP, Jones A, King DM, Moskovic EC. The role of percutaneous nephrostomy in malignant urinary tract obstruction. Clin Radiol 1993;47:32-5.
https://doi.org/10.1016/S0009-9260(05)81210-3
Sise JG, Crichlow RW. Obstruction due to malignant tumors. Semin Oncol 1978;5:213-24.
Nagle RB, Bulger RE, Cutler RE, Jervis HR, Benditt EP. Unilateral obstructive nephropathy in the rabbit. I. Early morphologic, physiologic and histological changes. Lab Invest 1973;28:456-67.
Klahr S. Obstructive nephropathy. Nephrology forum. Kid Intern 1998;54:286-300.
https://doi.org/10.1007/978-94-011-5482-6_56
Klahr S. Urinary tract obstruction. En: Schrier RW, Gottschalk CW, editores. Diseases of the Kidney. Boston: Little, Brown & Co.; 1997. P.709-38.
Emmert C, Rassler J, Kohler U, Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer. Arch Gynecol Obstet 1997;259:147-51.
https://doi.org/10.1007/BF02505324
Rose PG Operative retroperitoneal ureteral catheterization for obstructive uropathy in primary locally advanced carcinoma of the cervix: description of a technique and experience. Gynecol Oncol 1996;61:79-82.
https://doi.org/10.1006/gyno.1996.0100
Lau MW, Temperley DE, Mehta S, Johnson RJ, Barnard RJ, Clarke NW Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease. Br J Urol 1995;76:565-9.
https://doi.org/10.1111/j.1464-410X.1995.tb07779.x
Lutaif NA, Yu L, Abdulkader RC. Factors influencing the non-recovery of renal function after the relief of urinary tract obstruction in women with cancer of cervix. Ren Fail 2003;25:215-23.
https://doi.org/10.1081/JDI-120018722
Feng MI, Bellman GC, Shapiro CE. Management of ureteral obstruction secondary to pelvic malignancies. J Endourol 1999;13:521-4.
https://doi.org/10.1089/end.1999.13.521
Bohle A, Mackensen-Haen S, Gise H. The consequences of tubulointerstitial changes for renal function in glomerulopathies. En: Amerio A, Cortelli P, Massry SE, Boston, Kluwer, editores. Tubulointerstitial Nephropathies. New York, New York University Press; 1991. p.29-40.
https://doi.org/10.1007/978-1-4615-3892-9_4
Harris KPG, Schreiner GF, Klahr S. Effect of leukocyte depletion on the function of the post-obstructed kidney in the rat. Kidney Int 1989;36:210-5.
https://doi.org/10.1038/ki.1989.181
Hamdy EC, Williams JL. Use of dexamethasone for ureteric obstruction in advanced prostate cancer; percutaneous nephrostomies can be avoided. Br J Urol 1992;75:782-5.
https://doi.org/10.1111/j.1464-410X.1995.tb07391.x
Dudley BS, Gershenson DM, Kavanagh JJ, Copeland LJ, Carrasco CH, Rutledge FN. Percutaneous nephrostomy catheter use in gynecologic malignancy: M.D. Anderson Hospital experience. Gynecol Oncol 1986;24:273-8.
https://doi.org/10.1016/0090-8258(86)90303-3
Cuervo SI, Cortés JA, Bermudez DC, Martínez T, Quevedo R, Arroyo CR Infecciones intrahospitalarias en el Instituto Nacional de Cancerología, 2001-2002. Rev Colomb Cancerol 2003;7:32-43.
Wagenlehner EME, Naber KG. Emergence of antibiotic resistance and prudent use of antibiotic therapy in nosocomially acquired urinary tract infections. Internal J Antimicrob Agent 2004;23(Suppl.l):S24-9.
https://doi.org/10.1016/j.ijantimicag.2003.09.004
Garibaldi RA, Burke JP, Brito MR, Millar MA, Smith CB. Meatal colonization and catheter associated bacteriuria. N Eng J Med 1980;303:316-8.
https://doi.org/10.1056/NEJM198008073030605
Livermore D, Brown DFJ, Quinn JP, Carmeli Y, Paterson DL, Yu VL. Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae? Clin Microbiol Infect 2004;10:84-5.
https://doi.org/10.1111/j.1469-0691.2004.00831.x
TalS,, Guller V, Levi S et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Infect 2005;50:296-305.
https://doi.org/10.1016/j.jinf.2004.04.004
Gadducci A, Madrigali A, Facchini V, Fioretti P. Percutaneous nephrostomy in patients with advanced or recurrent cervical cancer. Clin Exp Obstet Gynecol 1994;21:71-3.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Todos los derechos reservados.
